Churchill was founded in 1989 by practicing clinicians needing information about the impact of new therapies on patients often excluded from randomized controlled trials. Churchill designs comprehensive communications, education, advocacy, and outcomes programs incorporating the perspective of providers, patients, and caregivers. Our multidisciplinary account teams apply a clinical practice model that includes physicians, pharmacists, PAs, nurses, and other healthcare professionals with experience managing patients with rare diseases. Churchill is dedicated to a simple mission: Elevate the level of scientific accuracy and clinical relevance of industry-sponsored communications activities. Over the course of two decades, we have designed and implemented dozens of publication plans, clinical meetings, and educational programs for many of the world's largest biopharmaceutical companies. Our experience and the relationships we have established with opinion leaders, journals, and professional associations enable us to quickly prepare and disseminate important clinical data. www.churchillcommunications.com